Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
49%
OVERLAP
BY WEIGHT
17
# OF OVERLAPPING
HOLDINGS
BBH
26
HOLDINGS
71%
ALSO IN FBT
FBT
31
HOLDINGS
57%
ALSO IN BBH
SECTOR DRIFT (BBH minus FBT)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in FBT |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 14.7% | 4.1% | 4.1% |
|
AMGEN INC | 14.6% | 3.8% | 3.8% |
|
UNITED THERAPEUTICS CORP | 3.7% | 4.2% | 3.7% |
 |
ARGENX SE ADR | 5.8% | 3.6% | 3.6% |
|
VERTEX PHARMACEUTICALS INC | 7.9% | 3.3% | 3.3% |
BBH Overweight Relative to FBT
|
AMGEN INC | 10.8% |
|
GILEAD SCIENCES INC | 10.6% |
|
VERTEX PHARMACEUTICALS INC | 4.6% |
|
INSMED INC | 4.4% |
|
IQVIA HOLDINGS INC | 4.2% |
|
REGENERON PHARMACEUTICALS | 4.0% |
|
REVOLUTION MEDICINES, INC. | 2.9% |
|
ARGENX SE ADR | 2.2% |
|
CHARLES RIVER LABORATORIES | 1.3% |
 |
ICON PLC | 1.2% |
BBH Underweight Relative to FBT
|
AXSOME THERAPEUTICS, INC. | -4.1% |
|
ALKERMES PLC | -4.0% |
|
CORCEPT THERAPEUTICS INC | -4.0% |
|
EXELIXIS INC | -3.6% |
|
KRYSTAL BIOTECH, INC. | -3.5% |
|
HALOZYME THERAPEUTICS INC | -3.3% |
|
SAREPTA THERAPEUTICS INC | -3.1% |
 |
GENMAB A/S SPONSORED ADR | -2.9% |
|
ACADIA PHARMACEUTICALS INC | -2.9% |
|
VERACYTE INC | -2.6% |